Stocks and Investing Stocks and Investing
Mon, February 8, 2021

David Lewis Maintained (ZBH) at Buy with Increased Target to $180 on, Feb 8th, 2021


Published on 2024-10-27 15:33:27 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $170 to $180 on, Feb 8th, 2021.

David has made no other calls on ZBH in the last 4 months.



There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jason Wittes of "Northland Capital Markets" Initiated at Hold and Held Target at $150 on, Tuesday, October 20th, 2020


These are the ratings of the 7 analyists that currently disagree with David


  • Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $192 on, Friday, February 5th, 2021
  • David Turkaly of "JMP Securities" Maintained at Buy with Increased Target to $180 on, Wednesday, January 27th, 2021
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Increased Target to $173 on, Monday, January 25th, 2021
  • Matthew O'Brien of "Piper Sandler" Maintained at Buy with Increased Target to $185 on, Friday, January 8th, 2021
  • Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $175 on, Monday, January 4th, 2021
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $180 on, Wednesday, December 16th, 2020
  • Jeff Johnson of "Baird" Maintained at Buy and Held Target at $154 on, Monday, November 9th, 2020

Contributing Sources